Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Among adult patients with chronic kidney disease undergoing hemodialysis, what is the efficacy and safety of virgin coconut oil compared to mineral oil as a therapeutic moisturizer for uremic xerosis?
Objectives of the Study: The general objective of this study is to assess the efficacy and safety of virgin coconut oil (VCO) compared to mineral oil as a therapeutic moisturizer for uremic xerosis. The specific objectives are as follows: 1) to determine and compare changes in the over-all dry skin score within and between treatment groups at baseline, 2 weeks-post and 4-weeks post application; 2) to quantitatively measure the following skin parameters at baseline, 2-weeks and 4-weeks post application (skin hydration using a corneometer, skin lipids using a sebumeter); 3) to determine and compare changes in quality of life scores within and between treatment groups at baseline, and 4-weeks post application; and 4) to identify the adverse effects of virgin coconut oil and mineral oil when used as moisturizer for uremic xerosis
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Virgin Coconut Oil | Experimental |
| |
| Mineral Oil | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Virgin Coconut Oil | Other | Virgin coconut oil applied to the test site twice daily for four weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in baseline overall dry skin score | 4 weeks | |
| Change in baseline corneometer readings | Measurement of skin hydration | 4 weeks |
| Change in baseline sebumeter readings | Measurement of skin lipids | 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Quality of life scores | 4 weeks | |
| Patient-assessed efficacy | 4 weeks | |
| Adverse events |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jacqueline Michelle G de las Alas, MD | University of the Philippines | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D008899 | Mineral Oil |
| ID | Term |
|---|---|
| D010577 | Petrolatum |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Mineral Oil | Other | Mineral oil applied to the test site twice daily for four weeks |
|
| 4 weeks |